• Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA 02215
  • 617-667-4074

The Berenson-Allen Center for Noninvasive Brain Stimulation (BA-CNBS) was established with the generous support of Helaine B. Allen and Alvin B. Allen, Theodore S. and Cynthia L. Berenson through the Theodore W. and Evelyn G. Berenson Charitable foundation.

Our center is a world leader in research and development, clinical application, and teaching of noninvasive brain stimulation.

Noninvasive brain stimulation is used to gain novel insights into the human brain and mind.

Work done by the BA-CNBS has been fundamental in establishing noninvasive brain stimulation as a valuable tool in clinical and fundamental neuroscience, improving the technology and its integration with several brain-imaging methodologies, and helping to create the field of therapeutic noninvasive brain stimulation.

The center is committed to provide education and training on the use of noninvasive brain stimulation for both clinical practice and research.

The BA-CNBS clinical program offers noninvasive brain stimulation for diagnostic applications and treatment of a variety of neuropsychiatric disorders such as depression, schizophrenia, epilepsy, dystonia, Parkinson’s disease, chronic pain, epilepsy, autism, and the neurorehabilitation of motor function, cognition, and language after stroke or traumatic brain injury.

  • Our Approach

    The Berenson-Allen Center for Noninvasive Brain Stimulation has been on the forefront of TMS therapy for the past decade. The center has successfully treated hundreds of patients producing a sustained improvement in patients’ moods allowing many to work and have fulfilling lives. Our clinicians and investigators continue to seek ways to improve the efficacy of TMS in the treatment of depression through ongoing research.

    For detailed information regarding treatment offered through BA-CNBS, please click here.